# Eidos Therapeutics, Inc. (EIDX)

Source: https://www.quantisnow.com/company/EIDX
Generated: 2026-11-17T23:24:06.012Z

- Ticker: EIDX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Major Pharmaceuticals
- IPO year: 2018

## Latest EIDX news and filings

- 2021-06-28 23:10 UTC [Leadership Update] [BIOMEA Fusion Strengthens its Executive Team with Appointment of Franco Valle as Chief Financial Officer](https://www.quantisnow.com/insight/biomea-fusion-strengthens-its-executive-team-with-appointment-of-franco-1177391)
- 2021-02-25 12:30 UTC [BridgeBio Pharma, Inc. Reports Fourth Quarter And Full Year 2020 Financial Results And Business Update](https://www.quantisnow.com/insight/bridgebio-pharma-inc-reports-fourth-quarter-and-full-year-2020-431711)
- 2021-02-05 21:30 UTC [SEC Form 15-12B filed](https://www.quantisnow.com/insight/sec-form-15-12b-filed-359059)
- 2021-01-29 00:50 UTC [SEC Form 4] [SEC Form 4: C Jonathan Fox gifted 500 units of Common Stock, decreasing ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-c-jonathan-fox-gifted-500-units-of-327811)
- 2021-01-29 00:39 UTC [SEC Form 4] [SEC Form 4 filed by Douglas Rohlen](https://www.quantisnow.com/insight/sec-form-4-filed-by-douglas-rohlen-327793)
- 2021-01-29 00:22 UTC [SEC Form 4] [SEC Form 4 filed by Franco Valle](https://www.quantisnow.com/insight/sec-form-4-filed-by-franco-valle-327771)
- 2021-01-29 00:15 UTC [SEC Form 4] [SEC Form 4: Cameron Turtle decreased ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-cameron-turtle-decreased-ownership-by-100-to-327760)
- 2021-01-29 00:08 UTC [SEC Form 4] [SEC Form 4 filed by J. Ali Satvat](https://www.quantisnow.com/insight/sec-form-4-filed-by-j-ali-satvat-327752)
- 2021-01-29 00:06 UTC [SEC Form 4] [SEC Form 4 filed by William Lis](https://www.quantisnow.com/insight/sec-form-4-filed-by-william-lis-327749)
- 2021-01-29 00:04 UTC [SEC Form 4] [SEC Form 4 filed by Sawochka Suzanne Hooper](https://www.quantisnow.com/insight/sec-form-4-filed-by-sawochka-suzanne-hooper-327740)
- 2021-01-29 00:00 UTC [SEC Form 4] [SEC Form 4: Uma Sinha gifted 3,000 units of Common Stock, decreasing ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-uma-sinha-gifted-3000-units-of-common-327730)
- 2021-01-28 05:15 UTC [SEC Form EFFECT filed](https://www.quantisnow.com/insight/sec-form-effect-filed-323241)
- 2021-01-26 21:10 UTC [SEC Form POS AM filed](https://www.quantisnow.com/insight/sec-form-pos-am-filed-317090)
- 2021-01-26 21:10 UTC [SEC Form S-8 POS filed](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-317087)
- 2021-01-26 21:10 UTC [SEC Form S-8 POS filed](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-317085)
- 2021-01-26 21:10 UTC [SEC Form S-8 POS filed](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-317084)
- 2021-01-26 13:47 UTC [SEC Form 25-NSE filed](https://www.quantisnow.com/insight/sec-form-25-nse-filed-314593)
- 2021-01-26 13:46 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-314592)
- 2021-01-26 13:30 UTC [BridgeBio Pharma, Inc. Announces Completion of Merger with Eidos Therapeutics, Inc.](https://www.quantisnow.com/insight/bridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-314439)
- 2021-01-20 21:23 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-299114)
- 2021-01-19 21:01 UTC [Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Approve BridgeBio Pharma, Inc. Acquisition of Eidos Therapeutics, Inc.](https://www.quantisnow.com/insight/stockholders-of-bridgebio-pharma-inc-and-eidos-therapeutics-inc-approve-295102)
- 2021-01-15 21:05 UTC [SEC Form 4: Uma Sinha sold $1,238,856 worth of Common Stock (10,000 units at $123.89), decreasing ownership by 3% to 306,525 units](https://www.quantisnow.com/insight/sec-form-4-uma-sinha-sold-1238856-worth-of-common-289076)
- 2021-01-13 21:49 UTC [SEC Form 425 filed](https://www.quantisnow.com/insight/sec-form-425-filed-282569)
- 2021-01-13 21:30 UTC [BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Announce January 21, 2021 Election Deadline for Merger](https://www.quantisnow.com/insight/bridgebio-pharma-inc-and-eidos-therapeutics-inc-announce-january-21-282463)
- 2021-01-13 21:05 UTC [SEC Form 4: Franco Valle exercised 3,247 units of Common Stock at a strike of $7.24 and sold $407,580 worth of Common Stock (3,247 units at $125.53)](https://www.quantisnow.com/insight/sec-form-4-franco-valle-exercised-3247-units-of-common-282254)
- 2021-01-12 12:32 UTC [SEC Form 425 filed](https://www.quantisnow.com/insight/sec-form-425-filed-275864)
- 2021-01-12 12:31 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-275863)
- 2021-01-07 21:02 UTC [SEC Form 425 filed](https://www.quantisnow.com/insight/sec-form-425-filed-266702)
- 2021-01-04 12:30 UTC [Leadership Update] [Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma and Eidos Therapeutics Stockholders Vote “FOR” Proposed Merger](https://www.quantisnow.com/insight/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-249070)
- 2020-12-29 12:31 UTC [SEC Form 4 filed](https://www.quantisnow.com/insight/sec-form-4-filed-242146)
- 2020-12-28 21:31 UTC [SEC Form 4 filed](https://www.quantisnow.com/insight/sec-form-4-filed-240923)
- 2020-11-09 22:15 UTC [SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigation of Eidos Therapeutics, Inc. Buyout](https://www.quantisnow.com/insight/shareholder-alert-rigrodsky-long-pa-reminds-investors-of-investigation-of-146720)
- 2020-11-08 00:49 UTC [SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Investors are Encouraged to Contact the Firm – EIDX, WTRE, ARA, CIT](https://www.quantisnow.com/insight/shareholder-investigation-halper-sadeh-llp-investigates-the-following-mergers-investors-143819)
- 2020-11-07 03:27 UTC [SHAREHOLDER ALERT: WeissLaw LLP Reminds EIDX, GLIBA, and EV Shareholders About Its Ongoing Investigations](https://www.quantisnow.com/insight/shareholder-alert-weisslaw-llp-reminds-eidx-gliba-and-ev-shareholders-143644)
- 2020-11-06 12:01 UTC [Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc., BMC Stock Holdings, Inc., Callaway Golf Company, Cellular Biomedicine Group, Inc., CIT Group Inc., Eidos Therapeutics, Inc., Watford Holdings Ltd. and Yintech Investment Holdings Limited](https://www.quantisnow.com/insight/lifshitz-law-firm-pc-announces-investigation-of-american-renal-associates-142710)
- 2020-11-05 12:30 UTC [BridgeBio Pharma, Inc. Reports Third Quarter 2020 Financial Results And Business Update](https://www.quantisnow.com/insight/bridgebio-pharma-inc-reports-third-quarter-2020-financial-results-and-139725)
- 2020-10-31 22:57 UTC [ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm - EIDX, RESI, PE, ARA](https://www.quantisnow.com/insight/alert-halper-sadeh-llp-reminds-shareholders-about-its-ongoing-merger-131215)
- 2020-10-31 01:41 UTC [SHAREHOLDER ALERT: WeissLaw LLP Reminds VRTU, GLIBA, EV and EIDX Shareholders About Its Ongoing Investigations](https://www.quantisnow.com/insight/shareholder-alert-weisslaw-llp-reminds-vrtu-gliba-ev-and-eidx-131106)
- 2020-10-30 19:31 UTC [Lifshitz Law Firm, P.C. Announces Investigation of Callaway Golf Company (NYSE: ELY), Eidos Therapeutics, Inc. (NASDAQ:  EIDX), Inphi Corporation (NASDAQ: IPHI), and Watford Holdings Ltd. (NASDAQ:WTRE)](https://www.quantisnow.com/insight/lifshitz-law-firm-pc-announces-investigation-of-callaway-golf-company-130738)
- 2020-10-29 20:30 UTC [Eidos Therapeutics Reports Third Quarter 2020 Financial Results and Business Update](https://www.quantisnow.com/insight/eidos-therapeutics-reports-third-quarter-2020-financial-results-and-business-128664)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/EIDX
- Earnings history: https://www.quantisnow.com/earnings/EIDX
- Dividend history: https://www.quantisnow.com/dividends/EIDX
- Insider transactions: https://www.quantisnow.com/insiders/EIDX
- Options chain: https://www.quantisnow.com/options/EIDX
- SEC 8-K filings only: https://www.quantisnow.com/company/EIDX/8-k
- RSS and alerts for EIDX: https://www.quantisnow.com/docs/rss-feeds.md
